Boston Partners’s Nature's Sunshine NATR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.28M Buy
220,193
+9,649
+5% +$239K 0.01% 481
2025
Q4
$4.54M Buy
+210,544
New +$3.86M ﹤0.01% 478
2025
Q3
Sell
-16,210
Closed -$240K 785
2025
Q2
$240K Buy
+16,210
New +$219K ﹤0.01% 699
2024
Q3
Sell
-157,582
Closed -$2.37M 744
2024
Q2
$2.37M Sell
157,582
-8,380
-5% -$143K ﹤0.01% 485
2024
Q1
$3.45M Sell
165,962
-7,501
-4% -$136K ﹤0.01% 462
2023
Q4
$3M Sell
173,463
-82,072
-32% -$1.42M ﹤0.01% 464
2023
Q3
$4.23M Sell
255,535
-38,899
-13% -$591K 0.01% 426
2023
Q2
$4.02M Sell
294,434
-17,042
-5% -$194K 0.01% 418
2023
Q1
$3.18M Sell
311,476
-17,431
-5% -$171K ﹤0.01% 428
2022
Q4
$2.74M Buy
+328,907
New +$2.78M ﹤0.01% 429

Other funds holding NATR

Boston Partners's NATR Position: Q1 2026 in Review

Boston Partners increased its Nature's Sunshine (NATR) stake by 4.6% in Q1 2026, buying an estimated $239K and bringing the position to 220,193 shares worth $5.28M. The position accounts for 0.01% of the portfolio, ranked #481.

Boston Partners first reported a position in NATR in Q4 2022 and has held it in 10 quarters since. 153 funds tracked by Wall St. Rank hold NATR as of Q1 2026.

  • Boston Partners held 220,193 shares of Nature's Sunshine worth $5.28M as of Q1 2026.
  • Boston Partners bought 9,649 Nature's Sunshine shares in Q1 2026, an estimated $239K.
  • Nature's Sunshine made up 0.01% of Boston Partners's portfolio in Q1 2026, its #481 holding.
  • Boston Partners first reported a position in Nature's Sunshine in Q4 2022 and has held it in 10 quarters since.
  • 153 funds tracked by Wall St. Rank held Nature's Sunshine as of Q1 2026.

Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.